Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Inhaled Ciclesonide Study in Preterm Infants — Stella

Home/Bronchopulmonary Dysplasia/Inhaled Ciclesonide Study in Preterm Infants

View on ClinicalTrials.gov

Recruiting

Back to Bronchopulmonary Dysplasia trials

Inhaled Ciclesonide Study in Preterm Infants

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Children's Mercy Kansas City, Kansas City, Missouri

Key details

Phase

Early testing

Sponsor

Venkatesh Sampath

Collaborators

University of Pittsburgh, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Enrollment target

~30 participants

Started

September 2025

Primary completion

August 2026

Age range

8 Days – 35 Days

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.